You are here:

duloxetine 30mg and 60mg capsules (Cymbalta)

Advice

Following a full submission

duloxetine (Cymbalta) is accepted for restricted use for the treatment of diabetic peripheral neuropathic pain in adults.

Duloxetine relieved peripheral neuropathic pain compared with placebo in patients with diabetes. It is restricted to initiation by prescribers experienced in the management of diabetic peripheral neuropathic pain as 2nd or 3rd line therapy.

Drug Details

Drug Name: duloxetine 30mg and 60mg capsules (Cymbalta)
SMC Drug ID: 285/06
Manufacturer: Eli Lilly and Company Ltd
Indication: Diabetic peripheral neuropathic pain in adults
BNF Category:
Sub Category: 4.3 Antidepressant drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 11 September 2006

Back